Edwin’s team found that GLO1 expression in the skeletal muscle of type 2 diabetic patients is regulated by NAMPT/SIRT, and supplementation with NR prevented the reduction of GLO1 expression and activity [94, 95]. This evidence concerns the gene GLO1 and type 2 diabetes mellitus.